PERY 21.95 Perry Ellis International Inc $PERY Hit a 52

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
PERY 21.95 Perry Ellis International Inc $PERY Hit a 52 week high of 22.28 Currently at 21.95 -0.05 -0.23% With a day low of 21.89 and a total volume of 7,385.

PERY Perry Ellis International Inc Recent Headline News

Perry Ellis International Announces Luggage Partnership With UGA Fashion
GlobeNewswire - Mon Nov 10, 8:00AM CST
Perry Ellis International, Inc. (Nasdaq ERY) announced today that it has entered into a new license agreement with UGA Fashion S.A. de C.V. to design, manufacture and market men's and women's luggage, travel bags, back packs and travel accessories ("luggage line" under the Perry Ellis(R) brand in Mexico.
PERY: 21.85 (-0.15)

Uptrend Call Working As Perry Ellis Stock Rises 21.6% (PERY)
Comtex SmarTrend(R) - Tue Nov 04, 9:45AM CST
SmarTrend identified an Uptrend for Perry Ellis (NASDAQ ERY) on May 22nd, 2014 at $16.59. In approximately 6 months, Perry Ellis has returned 21.58% as of today's recent price of $20.17.
PERY: 21.85 (-0.15)

Perry Ellis Up 21.0% Since SmarTrend Uptrend Call (PERY)
Comtex SmarTrend(R) - Tue Oct 28, 9:15AM CDT
SmarTrend identified an Uptrend for Perry Ellis (NASDAQ ERY) on May 22nd, 2014 at $16.59. In approximately 5 months, Perry Ellis has returned 21.04% as of today's recent price of $20.08.
PERY: 21.85 (-0.15)

26.6% Return Seen to Date on SmarTrend Perry Ellis Call (PERY)
Comtex SmarTrend(R) - Mon Oct 20, 5:01PM CDT
SmarTrend identified an Uptrend for Perry Ellis (NASDAQ ERY) on May 22nd, 2014 at $16.59. In approximately 5 months, Perry Ellis has returned 26.64% as of today's recent price of $21.01.
PERY: 21.85 (-0.15)

SUPERVALU Q2 Earnings in Line, Revenues Beat on Comps - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 17, 9:30AM CDT
SUPERVALU Inc.'s (SVU) second-quarter fiscal 2015 earnings per share of 11 cents were in line with the Zacks Consensus Estimate but declined 15.4% from the prior-year quarter figure of 13 cents.
PERY: 21.85 (-0.15), SVU: 8.66 (+0.04), GIL: 57.96 (-0.86), VFC: 70.52 (+0.73)

Estee Lauder to Boost Fragrance Portfolio with Le Labo - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 16, 3:00PM CDT
Estee Lauder Companies Inc. (EL) recently inked a definitive agreement to take over high-end fragrance and lifestyle brand Le Labo (The Lab) to strengthen its fragrance category.
PERY: 21.85 (-0.15), GIL: 57.96 (-0.86), VFC: 70.52 (+0.73), EL: 72.88 (+0.30)

Helen of Troy Posts In Line Q2 Earnings; Beats on Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 15, 8:20AM CDT
Helen of Troy Limited (HELE) reported second-quarter fiscal 2015 adjusted earnings of 99 cents, up 2.1% from the year-ago level.
HELE: 63.39 (-0.65), PERY: 21.85 (-0.15), GIL: 57.96 (-0.86), VFC: 70.52 (+0.73)

Original Penguin Announces New International Partnership With Kiona
GlobeNewswire - Tue Oct 14, 8:00AM CDT
Perry Ellis International, Inc. (PEI) (Nasdaq ERY) announced today that it has entered into a new license agreement with Kiona S.A. de C.V. to market men's and women's bags, messenger bags, IT carriers, camping bags, small leather goods, sports bags, travel bags, utility bags, backpacks, key chains and cosmetic bags under the Original Penguin(R) brand in Mexico.
PERY: 21.85 (-0.15)

Shares of PERY Up 20.4% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Oct 13, 11:05AM CDT
SmarTrend identified an Uptrend for Perry Ellis (NASDAQ ERY) on May 22nd, 2014 at $16.59. In approximately 5 months, Perry Ellis has returned 20.37% as of today's recent price of $19.97.
PERY: 21.85 (-0.15)

Perry Ellis Shares Up 23.1% Since SmarTrend's Buy Recommendation (PERY)
Comtex SmarTrend(R) - Mon Oct 06, 9:43AM CDT
SmarTrend identified an Uptrend for Perry Ellis (NASDAQ ERY) on May 22nd, 2014 at $16.59. In approximately 5 months, Perry Ellis has returned 23.09% as of today's recent price of $20.42.
PERY: 21.85 (-0.15)

Columbia Sportswear Launches PED TurboDown Jackets - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 03, 1:40PM CDT
Columbia Sportswear Inc. (COLM) launched its first Performance Enhanced Down (PED) insulating jacket, TurboDown.
PERY: 21.85 (-0.15), VFC: 70.52 (+0.73), COLM: 40.33 (-0.08), HBI: 110.64 (+1.31)

Perry Ellis International to Participate in Deutsche Bank Finance Leveraged Conference
GlobeNewswire - Thu Sep 25, 8:00AM CDT
Perry Ellis International, Inc. (Nasdaq ERY) announced today that the company will participate in the Deutsche Bank Finance Leveraged Conference on Tuesday, September 30, 2014 at the Phoenician Hotel in Scottsdale, AZ. A webcast of this presentation will be available live at the company's website (http://www.pery.com) and for 15 days following the conference.
PERY: 21.85 (-0.15), DB: 29.95 (-0.29)

Guess? (GES) Woes to Continue: Should You Dump It Now? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 24, 9:36AM CDT
On Sep 17, 2014, we issued an updated research report on Guess? Inc. (GES). The apparel retailer reported dismal second-quarter fiscal 2015 results on Aug 28.
GES: 21.45 (-0.30), PERY: 21.85 (-0.15), ANF: 28.54 (-0.96), KORS: 69.78 (-0.17)

Perry Ellis International Expands Partnership With American Traveler
GlobeNewswire - Thu Sep 18, 9:34AM CDT
Perry Ellis International, Inc. (PEI) (Nasdaq ERY) announced today that it is expanding its license agreement with American Traveler, Inc. granting rights under the Pro Player(R) brand to include sport duffels, backpacks, messenger bags, tote bags and sack packs.
PERY: 21.85 (-0.15)

Can Perry Ellis International (PERY) Keep the Earnings Streak Alive This Quarter? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Sep 16, 7:42AM CDT
Perry Ellis International has a solid Zacks Rank to a positive Earnings ESP and a positive earnings surprise happens nearly 70% of the time and so it is expected to deliver another beat in the next report.
PERY: 21.85 (-0.15)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 61

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 144

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Air Sealing First: Boosting Home Comfort & Efficiency

Updated Category News Views 69

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 181

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 28

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 80

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 149

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 252

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 96

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 331

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Warner Bros. Discovery's Remarkable Stock Surge Explained

Updated Category News Views 309

Warner Bros. Discovery Experiences Impressive Stock Surge Warner Bros. Discovery Inc. (NASDAQ: WBD) has been making headlines recently, with its stock surging dramatically. Investors and market enthusiasts are keenly observing this upward trend, particularly following a substantial rally. Record-Breaking Rally The company achieved an incredible milestone with its largest...

Continue Reading
Stellantis Reports 20% Q3 Shipment Drop, Market Reactions

Updated Category News Views 98

Stellantis Faces Significant Q3 Shipment Decline Stellantis (EPA: STLAM) (NYSE: STLA) recently reported a 20% drop in global shipments for the third quarter, prompting a notable reaction in the markets. The decline has been attributed to several factors including strategic inventory reduction measures and delays in the release of new models. During this challenging...

Continue Reading
Stifel Affirms Buy Rating on Elanco Amid New Drug Approval

Updated Category News Views 70

Stifel Stands Firm on Elanco Animal Health Stifel, a prominent financial services firm, has recently reaffirmed its Buy rating for Elanco Animal Health (NYSE: ELAN) and has kept its price target at $20.00 per share. This decision comes on the heels of the U.S. Food and Drug Administration's (FDA) approval of Elanco's new drug, Zenrelia, which serves as a significant boost...

Continue Reading
ChargePoint and Siemens Drive EV Infrastructure Innovation

Updated Category News Views 94

ChargePoint and Siemens Lead the Charge in Clean Tech The clean tech revolution is moving at an impressive pace, particularly with the growth of electric vertical takeoff and landing (eVTOL) aircraft and electric vehicle (EV) infrastructure. Companies like ChargePoint Holdings Inc (NYSE: CHPT) and Siemens AG (OTCPK: SIEGY) are crucial in shaping a sustainable future for...

Continue Reading
Elevance Health Faces Class Action: Investors Seek Remedies

Updated Category News Views 259

Opportunities for Investors in Elevance Health Class Action The recent developments surrounding Elevance Health, Inc. have prompted considerable attention, particularly among investors who have experienced substantial financial losses. The law firm Robbins Geller Rudman & Dowd LLP has initiated a class action lawsuit targeting Elevance Health, which operates in the health...

Continue Reading